Risk factors for clinical deterioration in patients admitted for COVID-19: A case-control study

被引:4
|
作者
Uranga, A. [1 ]
Villanueva, A. [2 ]
Lafuente, I [2 ]
Gonzalez, N. [2 ,3 ]
Legarreta, M. J. [2 ]
Aguirre, U. [2 ,3 ]
Espana, P. P. [1 ]
Quintana, J. M. [2 ,3 ]
Garcia-Gutierrez, S. [2 ,3 ]
机构
[1] Hosp Galdakao Usansolo, Serv Resp, Galdakao, Bizkaia, Spain
[2] Hosp Galdakao Usansolo, Unidad Invest, Galdakao, Bizkaia, Spain
[3] Red Invest Serv Sanitarios Enfermedades Cron REDI, Galdakao, Bizkaia, Spain
来源
REVISTA CLINICA ESPANOLA | 2022年 / 222卷 / 01期
关键词
COVID-19; Prognostic factors; Clinical deterioration;
D O I
10.1016/j.rce.2021.04.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: There is controversy regarding the best predictors of clinical deterioration in COVID-19. Objective: This work aims to identify predictors of risk factors for deterioration in patients hospitalized due to COVID-19. Methods Design: Nested case-control study within a cohort. Setting: 13 acute care centers of the Osakidetza-Basque Health Service. Participants: Patients hospitalized for COVID-19 with clinical deterioration-defined as onset of severe ARDS, ICU admission, or death-were considered cases. Two controls were matched to each case based on age. Sociodemographic data; comorbidities; baseline treatment; symptoms; date of onset; previous consultations; and clinical, analytical, and radiological variables were collected. An explanatory model of clinical deterioration was created by means of conditional logistic regression. Results: A total of 99 cases and 198 controls were included. According to the logistic regression analysis, the independent variables associated with clinical deterioration were: emergency department 0 2 saturation <= 90% (OR 16.6; 95%CI 4-68), pathological chest X-ray (OR 5.6; 95%CI 1.7-18.4), CRP >100 mg/dL (OR 3.62; 95%CI 1.62-8), thrombocytopenia with < 150,000 platelets (OR 4; 95%CI 1.84-8.6); and a medical history of acute myocardial infarction (OR 15.7; 95%CI, 3.29-75.09), COPD (OR 3.05; 95%CI 1.43-6.5), or HT (OR 2.21; 95%CI 1.11-4.4). The model's AUC was 0.86. On the univariate analysis, female sex and presence of dry cough and sore throat were associated with better clinical progress, but were not found to be significant on the multivariate analysis. Conclusion: The variables identified could be useful in clinical practice for the detection of patients at high risk of poor outcomes. (C) 2021 Elsevier Espana, S.L.U. and Sociedad Espanola de Medicina Interna (SEMI). All rights reserved.
引用
收藏
页码:22 / 30
页数:9
相关论文
共 50 条
  • [31] Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study
    Zhang, Jing
    Wang, Zhihua
    Wang, Xiong
    Hu, Zhiquan
    Yang, Chunguang
    Lei, Ping
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [32] Characteristics and Outcomes of COVID-19 Cancer Patients Admitted to a Portuguese Intensive Care Unit: A Case-Control Study
    Ranchor, Ridhi
    Pereira, Nuno
    Medeiros, Ana R.
    Magalhaes, Manuel
    Marinho, Anibal
    Araujo, Antonio
    CANCERS, 2023, 15 (12)
  • [33] Early identification of patients admitted to hospital for covid-19 at risk of clinical deterioration: model development and multisite external validation study
    Kamran, Fahad
    Tang, Shengpu
    Otles, Erkin
    McEvoy, Dustin S.
    Saleh, Sameh N.
    Gong, Jen
    Li, Benjamin Y.
    Dutta, Sayon
    Liu, Xinran
    Medford, Richard J.
    Valley, Thomas S.
    West, Lauren R.
    Singh, Karandeep
    Blumberg, Seth
    Donnelly, John P.
    Shenoy, Erica S.
    Ayanian, John Z.
    Nallamothu, Brahmajee K.
    Sjoding, Michael W.
    Wiens, Jenna
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 376
  • [34] Risk Factors for New Neurologic Diagnoses in Hospitalized Patients With COVID-19 A Case-Control Study in New York City
    Thakur, Kiran T.
    Chu, Victoria T.
    Hughes, Christine
    Kim, Carla Y.
    Fleck-Derderian, Shannon
    Barrett, Catherine E.
    Matthews, Elizabeth
    Balbi, Alanna
    Bilski, Amanda
    Chomba, Mashina
    Lieberman, Ori
    Jacobson, Samuel D.
    Agarwal, Sachin
    Roh, David
    Park, Soojin
    Ssonko, Vivian
    Silver, Wendy G.
    Vargas, Wendy D.
    Geneslaw, Andrew
    Bell, Michelle
    Waters, Brandon
    Rao, Agam
    Claassen, Jan
    Boehme, Amelia
    Willey, Joshua Z.
    Elkind, Mitchell S., V
    Sobieszczyk, Magdalena E.
    Zucker, Jason
    McCollum, Andrea
    Sejvar, James
    NEUROLOGY-CLINICAL PRACTICE, 2022, 12 (04) : E66 - E74
  • [35] Risk Factors for Pneumocystis jirovecii Pneumonia in Non-HIV Patients Hospitalized for COVID-19: A Case-Control Study
    Viceconte, Giulio
    Buonomo, Antonio Riccardo
    D'Agostino, Alessia
    Foggia, Maria
    Di Fusco, Antonio
    Pinchera, Biagio
    Scotto, Riccardo
    Iacovazzo, Carmine
    Fanasca, Luca
    Messina, Gaetana
    Cacciatore, Francesco
    Salvatore, Paola
    Gentile, Ivan
    JOURNAL OF FUNGI, 2023, 9 (08)
  • [36] Assessment of Potential Risk Factors, Characteristics, and Outcome of Pneumothorax and Pneumomediastinum in Patients with COVID-19: A Retrospective Case-control Study
    Kumar, T. Prasanna
    Madan, K.
    Arjun, A. S.
    Monica, N.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (11) : PC1 - PC6
  • [37] Respective roles of social deprivation, health literacy, and clinical factors for COVID-19: a case-control study in hospitalized patients
    Dahmane, Lotfi
    Julia, Chantal
    Vignier, Nicolas
    Sese, Lucile
    Brichler, Segolene
    Benainous, Ruben
    Bihan, Helene
    Lopez-Sublet, Marilucy
    Trawale, Damien
    Bouchaud, Olivier
    de Bouille, Jeanne Goupil
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [38] Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study
    Tigist W. Leulseged
    Degu G. Alemahu
    Ishmael S. Hassen
    Endalkachew H. Maru
    Wuletaw C. Zewde
    Negat W. Chamiso
    Kalkidan T. Yegele
    Daniel S. Abebe
    Firaol M. Abdi
    Etsegenet Y. Minyelshewa
    Tegenu G. Gerbi
    Helen T. Hagos
    BMC Infectious Diseases, 21
  • [39] Predictive factors of hospitalization in an intensive care unit in patients with COVID-19: A case-control study
    Da Silva, Palena Cabral
    Diniz, Alcides da Silva
    De Noronha, Gisele Almeida
    Diniz Araujo, Maria Lucia
    Cabral, Poliana Coelho
    NUTRICION CLINICA Y DIETETICA HOSPITALARIA, 2021, 41 (01): : 123 - 129
  • [40] Factors associated with development of symptomatic disease in Ethiopian COVID-19 patients: a case-control study
    Leulseged, Tigist W.
    Alemahu, Degu G.
    Hassen, Ishmael S.
    Maru, Endalkachew H.
    Zewde, Wuletaw C.
    Chamiso, Negat W.
    Yegele, Kalkidan T.
    Abebe, Daniel S.
    Abdi, Firaol M.
    Minyelshewa, Etsegenet Y.
    Gerbi, Tegenu G.
    Hagos, Helen T.
    BMC INFECTIOUS DISEASES, 2021, 21 (01)